MDM2 and neoplasm: To further investigate whether MDM2 blockade may lead to sensitization of tumor cells to T-cell-mediated killing, we pre-treated tumor cells with 0 or 1 μM AMG-232 for 8 hours followed by T-cell co-culture with 0 or 1 μM AMG-232 for another 16 hours.